scispace - formally typeset
Search or ask a question
Author

Olamide Alabi

Other affiliations: Emory Healthcare
Bio: Olamide Alabi is an academic researcher from Emory University. The author has contributed to research in topics: Pandemic & Mental health. The author has an hindex of 2, co-authored 12 publications receiving 11 citations. Previous affiliations of Olamide Alabi include Emory Healthcare.

Papers
More filters
Journal ArticleDOI
TL;DR: A review of the literature outlines the unique barriers to health and disparities that are associated with vulnerable communities who have been most impacted by the COVID-19 pandemic in the United States as discussed by the authors.

26 citations

Journal ArticleDOI
TL;DR: In this article, the authors comprehensively review current literature and better understand the impact of blood type on viral susceptibility and outcomes, and investigate the association between blood type and COVID-19 infection.

24 citations

Journal ArticleDOI
TL;DR: The epidemiology, risk factors, clinical evaluation, and management of patients with premature PAD are discussed, including prevention of cardiovascular events, improvement of symptoms and functional status, and prevention of adverse limb events.

18 citations


Cited by
More filters
Journal ArticleDOI
TL;DR: In this article, the authors present a review of medical education developments in response to COVID-19; however, the field has rapidly changed in the past few years, and they do not address the issues raised by COVID19.
Abstract: COVID-19 has fundamentally altered how education is delivered. Gordon et al. previously conducted a review of medical education developments in response to COVID-19; however, the field has rapidly ...

132 citations

Journal ArticleDOI
TL;DR: It was determined that individuals with Long-COVID showed significantly increased levels of functional memory cells with high antiviral cytotoxic activity such as CD8+ TEMRA cells, CD8±TCRγδ+ cells, and NK cells with CD56+CD57+NKG2C+ phenotype.
Abstract: Long-COVID is a new emerging syndrome worldwide that is characterized by the persistence of unresolved signs and symptoms of COVID-19 more than 4 weeks after the infection and even after more than 12 weeks. The underlying mechanisms for Long-COVID are still undefined, but a sustained inflammatory response caused by the persistence of SARS-CoV-2 in organ and tissue sanctuaries or resemblance with an autoimmune disease are within the most considered hypotheses. In this study, we analyzed the usefulness of several demographic, clinical, and immunological parameters as diagnostic biomarkers of Long-COVID in one cohort of Spanish individuals who presented signs and symptoms of this syndrome after 49 weeks post-infection, in comparison with individuals who recovered completely in the first 12 weeks after the infection. We determined that individuals with Long-COVID showed significantly increased levels of functional memory cells with high antiviral cytotoxic activity such as CD8+ TEMRA cells, CD8±TCRγδ+ cells, and NK cells with CD56+CD57+NKG2C+ phenotype. The persistence of these long-lasting cytotoxic populations was supported by enhanced levels of CD4+ Tregs and the expression of the exhaustion marker PD-1 on the surface of CD3+ T lymphocytes. With the use of these immune parameters and significant clinical features such as lethargy, pleuritic chest pain, and dermatological injuries, as well as demographic factors such as female gender and O+ blood type, a Random Forest algorithm predicted the assignment of the participants in the Long-COVID group with 100% accuracy. The definition of the most accurate diagnostic biomarkers could be helpful to detect the development of Long-COVID and to improve the clinical management of these patients.

29 citations

Journal ArticleDOI
TL;DR: In this article , the authors compared the incidence of endpoints marking delayed healthcare seeking in medical emergencies, before and during the COVID-19 pandemic, based on a PICO model.
Abstract: Apart from infecting a large number of people around the world and causing the death of many people, the COVID-19 pandemic seems to have changed the healthcare processes of other diseases by changing the allocation of health resources and changing people's access or intention to healthcare systems.To compare the incidence of endpoints marking delayed healthcare seeking in medical emergencies, before and during the pandemic.Based on a PICO model, medical emergency conditions that need timely intervention was selected to be evaluated as separate panels. In a systematic literature review, PubMed was quarried for each panel for studies comparing the incidence of various medical emergencies before and during the COVID-19 pandemic. Markers of failure/disruption of treatment due to delayed referral were included in the meta-analysis for each panel.There was a statistically significant increased pooled median time of symptom onset to admission of the acute coronary syndrome (ACS) patients; an increased rate of vasospasm of aneurismal subarachnoid hemorrhage; and perforation rate in acute appendicitis; diabetic ketoacidosis presentation rate among Type 1 Diabetes Mellitus patients; and rate of orchiectomy among testicular torsion patients in comparison of pre-COVID-19 with COVID-19 cohorts; while there were no significant changes in the event rate of ruptured ectopic pregnancy and median time of symptom onset to admission in the cerebrovascular accident (CVA) patients.COVID-19 has largely disrupted the referral of patients for emergency medical care and patient-related delayed care should be addressed as a major health threat.

19 citations

Journal ArticleDOI
TL;DR: Institutional and instructional reforms are listed to assess what has happened to health-professional education since the publication of the Lancet Commission and how the COVID-19 pandemic altered the education process.

16 citations